M2 macrophages have been demonstrated to reduce tumor-infiltrating lymphocytes, especially CD8+ T cells, by reducing the expression of chemokines and promoting the production of extracellular matrix (Peranzoni et al., 2018; Pan et al., 2020). This evidence concerns the gene CD8A and neoplasm.